\nEULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs.
Josef S Smolen(Medical University of Vienna), Robert Landewé(Maastricht University Medical Centre), Ferdinand C. Breedveld(Leiden University Medical Center), Maxime Dougados(Délégation Paris 5), Paul Emery(University of Leeds), C. Gaujoux-Viala(Délégation Paris 5), Simone Gorter(Maastricht University Medical Centre), Rachel Knevel(Leiden University Medical Center), J. Nam(University of Leeds), Monika Schoels(Klinik Hietzing), Daniel Aletaha(Medical University of Vienna), Maya H Buch(University of Leeds), Laure Gossec(Délégation Paris 5), T. Huizinga(Leiden University Medical Center), J. W. J. Bijlsma(University Medical Center Utrecht), Gerd R Burmester(Humboldt-Universität zu Berlin), Bernard Combe(Université de Montpellier), Maurizio Cutolo(University of Genoa), Cem Gabay(University Hospital of Geneva), Juan J. Gómez‐Reino(Universidade de Santiago de Compostela), Marios Kouloumas(European League Against Rheumatism), Tore K Kvien(Diakonhjemmet Hospital), E. Martín‐Mola(Hospital Universitario La Paz), Iain B. McInnes(University of Glasgow), Karel Pavelká(Charles University), Piet L. C. M. van Riel(Radboud University Nijmegen), M. Scholte(European League Against Rheumatism), David L. Scott(King's College School), Tuulikki Sokka(Central Finland Health Care District), Guido Valesini(Sapienza University of Rome), Ronald van Vollenhoven(Karolinska University Hospital), Kevin Winthrop(Oregon Health & Science University), John B. Wong(Tufts University), A. Zink(German Rheumatism Research Centre), Désirée van der Heijde(Leiden University Medical Center)
Cited by 1,625Open Access
Abstract
\n Contains fulltext :\n 88773.pdf (Publisher’s version ) (Closed access)\n
Related Papers
No related papers found
Powered by citation graph analysis